Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00088803 · ClinicalTrials.gov registry record
DNA Variations in the Gene in Young Patients With Wilms' Tumor
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 471
- Enrollment target
NCT00088803: Completed study, sponsored by Children's Oncology Group.
NCT00088803 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 471 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00088803 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms' tumor.
Interventions
- GENETIC polymerase chain reaction
- GENETIC molecular genetic technique
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2004-08 |
What the finished NCT00088803 record still lists
NCT00088803 is an observational study that tracks outcomes without assigning an intervention. The registered 471 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which polymerase chain reaction is the first listed.
NCT00088803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00088803 about?
NCT00088803 is a clinical study titled "DNA Variations in the Gene in Young Patients With Wilms' Tumor". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms' t...
What is the current status of trial NCT00088803?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2004-08.
What interventions are being tested in trial NCT00088803?
The interventions under investigation include: polymerase chain reaction (GENETIC), molecular genetic technique (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00088803?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
- NCT05201404 · 471 participants · Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia